However, some studies have shown high values of serum resistin in women with breast cancer independent of BMI (49, 59), different from what was observed in the present study, in which obesity was a determining factor for hyperresistinemia, which is enhanced in the presence of the tumor. This evidence concerns the gene RETN and breast carcinoma.